FeaturedBiogen will stop selling its controversial Alzheimer’s drug Aduhelm Associated Press, January 31, 2024
HealthAlzheimer’s drug Leqembi has full FDA approval now and that means Medicare will pay for it Associated Press, July 6, 2023
